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nuclear RNA-seq with greater resolution spatial transcriptomics will allow spatial mapping of kidney disease of varying aetiology to further reveal
the patterning of immune cells and non-immune renal cells.
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Kidney disease represents a global health burden of increasing prevalence and is an 
independent risk factor for cardiovascular disease. Myeloid cells are a major cellular 
compartment of the immune system; they are found in the healthy kidney and in increased 
numbers in the damaged and/or diseased kidney, where they act as key players in the 
progression of injury, inflammation and fibrosis. They possess enormous plasticity and 
heterogeneity, adopting different phenotypic and functional characteristics in response to 
stimuli in the local milieu. Though this inherent complexity remains to be fully understood in 
the kidney, advances in single-cell genomics promises to change this. Specifically, single-cell 
RNA sequencing (scRNA-seq) has had a transformative effect on kidney research, enabling 
the profiling and analysis of the transcriptomes of single cells at unprecedented resolution 
and throughput, and subsequent generation of cell atlases. Moving forward, combining 
scRNA- and single-nuclear RNA-seq with greater resolution spatial transcriptomics will 
allow spatial mapping of kidney disease of varying aetiology to further reveal the patterning 
of immune cells and non-immune renal cells. 
This review summarises the roles of myeloid cells in kidney health and disease, the 
experimental workflow in currently available scRNA-seq technologies and published 


















The kidney is a complex organ that performs diverse functions essential for physiological 
homeostasis and consequently, patients with kidney disease often present with significant 
complications and comorbidities
1-2
. The manifestations of kidney disease are wide-ranging, 
encompassing acute kidney injury (AKI), autoimmune disorders and rejection of kidney 
transplants, all of which are directly or indirectly immune-mediated
3
. Due to an increased 
prevalence rate, kidney disease is having a major effect on global health, both as a direct 




Myeloid cells are the most abundant nucleated haematopoietic cells in the body, 
encompassing monocytes, macrophages, dendritic cells (DCs) and granulocytes. They make 
up a critical arm of the immune system and have diverse functions
4
. In the kidney, 
macrophages and DCs have most notably been shown to influence organ homeostasis, injury 
and reparative processes following diverse insults. Their function, phenotypic spectrum and 





Our understanding of the immune system has advanced through the application of 
technologies that allow single cell resolution, primarily microscopy and flow cytometry. The 
number of parameters that can be measured simultaneously with these is limited and reliant 
on prior knowledge of which antigens are present. Over recent years, progress in single-cell 
RNA sequencing (scRNA-seq), which aims to measure the expression levels of genes in cells 




Roles of myeloid cells in kidney health and disease  
Myeloid cells have an adaptive nature, demonstrating transient responses, controlled 
differentiation, and (re)location into tissues as well as plasticity in response to various 
environmental stimuli, whether they are homeostatic or inflammatory
4
. This represents a 
complication regarding their study within the kidney, as this major haemo-filtration organ 
offers a challenging milieu that is not spatially uniform, and differences in immune cell types 
in the renal cortex and medulla have been reported
8,9
. 
Macrophages are the most abundant myeloid cell type in the kidney and, together with DCs, 
coordinate inflammatory responses to freely filtered antigenic material and safeguard the 
kidney from infection
8
. Importantly, they are also involved in initiation and progression of 
renal disease, as well as the subsequent tissue regeneration. Due to this diversity, it is 
generally suggested that macrophages are divided into proinflammatory (M1 or ‘classically 
activated’) and tissue reparative (M2 or ‘alternatively activated’) phenotypes. However, this 
characterisation is oversimplified with not only macrophages, but also DCs possessing 
inherent plasticity. Indeed, there is robust evidence for disease-associated myeloid cells 
sharing signature marker genes of both pro- and anti-inflammatory characteristics
4,10
. 
Immune cells are typically defined by different cell surface markers, though different 
myeloid cell types have many markers in common, therefore, several will often be required 
to identify the cell type of interest. In addition, markers can differ between species 
(Table. 1). Immunohistochemistry and flow cytometry are often used to identify both intra- 
and extracellular markers
6




) are of 
dual haematopoietic origin arising from the yolk-sac and from definitive haematopoiesis, 
with Ly6C
lo




















. Despite being limited to around 16 parameters and 
problems that arise from spectral overlap, flow cytometry in particular has been very useful 
and represents the most basic single cell technology, but it is unlikely to provide the full 




Overview of single-cell sequencing technologies 
High throughput gene expression techniques, such as microarray and bulk RNA-sequencing, 
have provided a better understanding of complex organ transcriptomes, however, their RNA 
input requirements have limited studies to pooled populations. As the kidney contains more 
than 20 distinct cell types including: epithelial, endothelial, mesenchymal, and immune 
populations, the resulting gene expression profile of renal tissue reflects only an average for 
these heterogeneous constituents
14
. Within the kidney the proximal tubule cells dominate in 
number, thus can obscure the expression profile of rarer populations. scRNA-seq 
technologies have addressed these limitations by enabling the objective investigation of 
transcriptomes of individual cells in a given sample, with generation of cell atlases of 
mammalian renal components. Notably, the kidney research community has been invested in 
open access and has made these data freely available via websites (Table. 2). This permits the 
unbiased assessment of cellular heterogeneity, identification of new cell states and subtypes, 
and dynamic cellular transitions at very high resolution and accuracy
6,14-15
. 
To date, a number of scRNA-seq techniques have been proposed, and the development of 
new protocols is a very active area of research (as reviewed by [16]). Generally, all scRNA-
seq experiments share a common workflow: sample preparation, single-cell capture, reverse 
transcription and transcriptome amplification, library preparation, sequencing, and analysis 
(Figure. 1). 
 
Single-nuclear sequencing (snRNASeq) is an increasingly popular alternative to scRNAseq. 
Here, nuclei are isolated from cells and used for droplet-based sequencing
14
. snRNA-seq has 
been reported to have comparable gene detection to scRNA-seq in the adult kidney and to 
eliminate dissociation-induced transcriptional stress responses in the inflamed fibrotic kidney. 
Moreover, it is compatible with frozen samples, but captures immune cells with lower 
efficiency
19
. The reason for this remains unclear. As such, it might be necessary to isolate 
CD45
+
 cells, which only account for 2-17% of the total kidney cell population
20
, in order to 
obtain the greatest possible insight into renal leukocytes using this method. 
 
Numerous other single-cell techniques are under development to allow the direct 
measurement of microRNA, proteomic or metabolic data, which scRNA-seq and snRNA-seq 
approaches do not provide. Most notably, simultaneous expression profiling of transcripts 
and cell surface proteins, such as RNA expression and protein (REAP)-seq
21
 and cellular 
indexing of transcriptomes and epitopes (CITE)-seq
22
 is now possible, permitting the 
correlation of protein expression with transcriptomic data. In addition, Assay for 
Transposase-Accessible Chromatin (ATAC)-seq allows profiling of chromatic accessibility 
enabling investigation of the epigenetic heterogeneity
23
. It has recently been used in 
combination with snRNA-seq to identify unique cell states within the proximal tubule and 
thick ascending limb in the human kidney
24
, as well as key chromatin remodelling events and 






Due to the kidney having distinct regional differences, anatomic localisation and intercellular 
interactions of cells is important, yet it is largely lost when analysing dissociated single cells. 
Interactions may be somewhat gleaned from receptor-ligand pair analyses for chemokines 
and cytokines, however, direct visualisation of the spatial relationships among cells is needed 
to fully answer such questions. This further means that it is not possible to discriminate 
leukocyte populations that infiltrate or reside in the kidney from those that may be circulating 
through the kidney vasculature
6,15
. Combining scRNA-seq and snRNA-seq with spatial 
transcriptomics may improve this aspect. Indeed, Ferriera and colleagues recently utilised 
these complementary technologies to spatially map the transcriptomic signature in mouse 
AKI models and demonstrated how this may be applied to human samples
26
. They identified 
patterns of immune and epithelial cell co-localisation and although this it was limited by 
resolution, it is likely to improve with future work. 
 
scRNA-seq studies in kidney health 
A comprehensive cellular anatomy of the normal kidney is crucial to completely understand 
the development and resolution of kidney disease yet to date, attempts to fully map immune 
populations in the kidney in health are limited. In 2018, Park and colleagues provided the 
first and largest scale murine kidney cell scRNA-seq so far from healthy mouse kidney
2
. 
They identified major cell subtypes that comprise the nephron and previously known renal 
immune cell types, including resident macrophages and neutrophils. However, it is possible 
that some myeloid subtypes were undetected, perhaps due to immune cell types contributing 
a small proportion in the uninjured kidney and/or due to sample preparation as approximately 
25% of cells did not pass quality control in this study. 
 
A recent key study used scRNA-seq with flow and mass cytometry to define the global 
immune landscape in healthy human adult and foetal kidneys, profiling cells across the 
lifespan
9
. Mononuclear phagocytes (MNPs), natural killer (NK) cells and T cells were most 
prevalent, and within the mature kidney myeloid compartment four subsets of MNPs, 
neutrophils, mast cells, and plasmacytoid DCs (pDCs) were identified. The MNP cluster was 
dominated by two monocyte-derived macrophage populations; one was transcriptionally 
similar to CD14
+
 classical monocytes, and the other to CD16
+
 non-classical monocytes. It 
also contained a conventional DC (cDC) population and tissue-macrophage population that 
was skewed toward an anti-inflammatory M2 transcriptome expressing CD206. In addition, 
researchers demonstrated anatomical localisation of immune cells by referencing their work 
to publicly available bulk RNA-seq data generated from known kidney regions, revealing 
differential distribution of immune subsets in the medulla and pelvis compared to the cortex. 
Analysis of ligand-receptor interactions, indicating epithelial and immune cell crosstalk, was 
predicted to localise antibacterial macrophages and neutrophils to regions of the kidney most 
susceptible to ascending infection from the urinary tract. This is in line with previous work 
that showed high interstitial sodium concentration of the medulla stimulates the production of 
chemokines by tubular epithelial cells, which helps position macrophages to counter the 
immunological threat posed by ascending bacterial infection
8
. The capability to orchestrate 
localisation of immune cells to specific regions was absent in foetal kidneys, with postnatal 
acquisition of transcriptional signatures indicative of roles in inflammation and immune 
defence
9
. Another recent study by Menon and colleagues identified resident immune cells in 
non-diseased human samples from tumour-nephrectomy, surveillance, and pre-perfusion 




Dynamic changes in the immune system are a hallmark of ageing
28
. Recently, scRNA-seq 
was performed on >350,000 cells from several organs and tissues taken from C57BL/6J mice 
belonging to age groups ranging from 1 to 30 months
29
. Following computation of overall 
diversity score, two clusters of renal macrophages were identified for which composition 
changed significantly with age. One cluster was mostly composed of cells from 1- and 3-
month-old mice enriched with an anti-inflammatory signature (e.g., Cq1a, Cd74, Cd81). 
Conversely, the other cluster was primarily composed of cells from 18-, 21-, 24- and 30-
month-old mice that resembled a proinflammatory macrophage state (e.g., Intgal, Msrb1). At 
present, such comprehensive ageing studies in humans are missing but these will be 




Though studies have been carried out on both human and mouse tissue, there are 
shortcomings in acquiring enough fresh human samples, highlighting the importance of 
overcoming translational issues. Studies have identified well defined markers of myeloid cell 
types across murine tissues, but they lack conservation across species. A well-known 
example is F4/80 (encoded by adgre1) which is used to identify tissue resident macrophages 
in mice but is not expressed by macrophage populations in humans. Furthermore, markers 
that were historically used to differentiate DCs from macrophages, such as CD11c and 
MHCII, are now known to be commonly expressed by tissue macrophages
28,30
. Zimmerman 





 cells with the lymphocyte population excluded were isolated from one 
mouse, rat, pig and human kidney, revealing a cluster of cells across all which express C1q. 




 have also 
identified this C1q-expressing cluster. In the C1q-expressing cluster, novel surface markers 
Cd74 and Cd81 were identified as potential candidate markers of kidney resident 
macrophages across species
31














) macrophages, and using the parabiotic mouse model they 
confirmed minimal exchange with bone marrow derived cells. It remains unknown if these 
candidates vary throughout the time course of inflammation. Indeed, C1qa expression varied 
over twelve myeloid subsets in our reversible-unilateral ureteral obstruction (R-UUO) 
study
10
. In future it will be important to further investigate the effect of mouse strain in order 
to contextualise findings. Indeed, inbred laboratory mouse strains can be highly divergent in 
their immune response patterns for example, after unilateral ischaemic reperfusion injury 





scRNA-seq studies in kidney injury and disease 
A phase-dependent influx of myeloid cells and changes in their phenotype occur during the 
time course of kidney diseases
34
. To define the cellular landscape in the progression of AKI 
to chronic kidney disease (CKD), do Valle Duraes and colleagues employed sc-RNAseq in a 
unilateral IRI model with or without immediate contralateral nephrectomy to study kidney 
regeneration or fibrosis, respectively
35
. Seven main clusters were identified including: 
resident and inflammatory macrophages, neutrophils/monocytes, DC/monocytes, NK cells, T 
and B cells. The healthy kidney was dominated by resident macrophages, whereas following 
injury inflammatory macrophages significantly expanded and resident macrophages 
disappeared, regardless of the model used or post-injury timepoint. The mixed populations of 
neutrophils/monocytes and DC/monocytes also expanded after injury. In another study, 
snRNA-seq was used with a bilateral IRI model of AKI
36
. Though proximal tubules were the 
focus here, six leukocyte clusters were identified: three macrophage subtypes, DCs, T and B 
cells. Ligand-receptor analysis performed on the combined leukocyte cluster suggested 
changes in Ccl2 (tubulointerstitium) to Ccr2 (leukocytes) signalling over time; fibroblasts and 
endothelial cells were the first cell types to signal leukocytes, followed by leukocyte-
leukocyte signalling and increasing Ccl2-Ccr2 signalling from proximal tubules that failed to 
repair at 2 days and 6 weeks post-injury. The first and second macrophage cluster are likely 
resident and inflammatory macrophages, based on markers such as F13a1 and Vcan. The 
third cluster expressed high levels of Mmp12, a macrophage-specific metalloproteinase, and 
Gpnmb, a negative regulator of inflammation proposed to promote M2 polarisation. This and 
the DC cluster were most abundant at 2- and 6 weeks post-injury, in which the kidney is in 
the reparative phase. Our group recently used scRNA-seq in the mouse R-UUO model, in 
which regression of established tubulointerstitial fibrosis, a hallmark of CKD, occurs 
following reversal of obstruction
10
. Interestingly, we also reported a macrophage cluster that 
was solely in kidneys that had undergone UUO reversal; it was also characterised by 
expression of Mmp12 and scavenger receptors, including Gpnmb and Mrc1. We have 
previously reported a similar Mmp12
+
 macrophage in liver during the resolution of liver 
disease
37
. Whilst these Mmp12
+
 cells mapped to macrophages on the ImmGen database, they 
morphologically resembled monocytes and expressed high levels of Ccr2 but low levels of 
F4/80 by immunofluorescence. Furthermore, their transcriptome most closely aligned to 
monocytes infiltrating the kidney during recovery from IRI. We found that bone marrow 
derived monocytes that were fed FITC labelled collagen increased their expression of Mmp12 
and Gpnmb, suggesting that phagocytosis of collagen may induce expression of these 
markers.  
In our characterisation of myeloid cells in renal injury and repair, we identified a further 
eleven myeloid cell subsets in the R-UUO model, including some with a novel phenotype. 
This was uniquely done by integrating droplet and plate based scRNA-seq with index linkage 
to map the subsets onto monocyte and macrophage gates on flow cytometry
10
. Three 
monocyte clusters were identified: patrolling and inflammatory subtypes, and a unique ‘pro-
fibrotic’ subtype expressing Arg1 that was exclusively present at UUO day 2 (acute injury 
phase). These Arg1
+
 cells expressed markers of Ly6C
+
 inflammatory monocytes, including 
Ccr2 and F13a1, though not Ly6c2. Moreover, they were shown to express hypoxia, pro-
fibrotic and pro-inflammatory genes, as well as genes encoding ECM components and ECM 
cross-linkers. Together with a number of ligand-receptor pairs revealed between Arg1
+
 
monocytes and mesenchymal cells, these data suggest Arg1
+ cells could be derived from 
recruited Ly6C
+ monocytes that become activated acutely toward a profibrotic phenotype in 
the hypoxic and inflammatory environment of the injured kidney. Indeed, there are waves of 
monocyte ingress during chronic progressive kidney injury
35
. Interestingly, in a model of 
renal injury due to sepsis, a subcluster of macrophages showed increased Arg1 expression in 
the later post-injury timepoints, albeit with markers of alternative macrophage activation, 
such as Mrc1
38
. We further tracked the fate of circulating immune cells recruited to the 
kidney using paired blood exchange (PBE), which holds advantages over parabiosis, with the 
donor cells persisting at large numbers in the circulation for a relatively short time, and, thus, 
permits the tracking of cells at multiple time points after injury or during resolution of 
disease. Combining PBE, flow cytometry and pseudotime analyses we showed early 
recruitment of donor monocytes to the obstructed kidney at UUO day 2; where at UUO day 7 
they transitioned to a CCR2
hi 
macrophages with a transcriptome almost identical to resident 
macrophages. Other work is indicative of CCR2
+ cells being detrimental; in an IRI model 
with CCR2 inactivation there was a reduction in the expansion of kidney F4/80 macrophages 
and severity of renal fibrosis
5
. It remains to be determined if these novel populations are 
present at all stages in the context of CKD; for example, are the Mmp12
+
 macrophages 
present at early points of injury where endogenous kidney repair mechanisms are active and 
attempting repair, or only when a scarred matrix is present with no ongoing injury stimulus?  
Dhillon and colleagues performed scRNA-seq analysis on healthy and fibrotic mouse kidneys 
from a folic acid nephropathy model
39
. Fourteen immune clusters were identified, compared 
to only five in their previous study
2
 including: macrophages, subclusters of DCs (CD11b+/-, 
pDC), granulocytes and lymphocytes. Another study compared scRNA-seq and snRNA-seq 
on obstructed (fibrotic) mouse kidney at UUO day 14. Both methods had comparable gene 
detection; however, compared with scRNA-seq, snRNA-seq had a reduced dissociation bias 
and dissociation-induced transcriptional stress responses
19
. One macrophage cluster was 
identified here, though researchers identified a novel “de-differentiated” proximal tubule 
cluster that expressed numerous secreted proinflammatory cytokines, including Ccl2, 
macrophage proliferative cytokine Il-34, and neutrophil chemo-attractants Cxcl1 and Cxcl2. 
This study, again, indicates that snRNA-seq is not as capable as scRNA-seq at detecting 
immune populations in the damaged and inflamed kidney. Indeed, the same group performed 
sn-RNAseq on cryopreserved human diabetic kidney samples
40
. Diabetic kidneys were found 
to have increased leukocyte numbers compared to control kidneys, as expected. Monocytes, 
plasma cells, T and B cells were detected, however, a macrophage population was not, 
despite the role of macrophages in type 2 diabetes being well-documented
41
. Researchers 
further compared their diabetic samples to publicly available peripheral blood mononuclear 
cell datasets as the leukocyte numbers in control samples was small. Increased inflammatory 
markers were observed in both infiltrating diabetic CD14
+
 monocytes and CD16
+
 monocytes.  
Recently, Kuppe and colleagues generated a single cell map of the human kidney, with a 
focus on the tubulointerstitium and fibrosis development in CKD
42
. However, in the CD10
-
 
(non-proximal tubular) sorted cells, three macrophage subtypes, monocytes, DCs and mast 
cells were identified, as well as NK, T and B cells. Researchers proposed a working model of 
the pathways involved in renal fibrosis, but immune cells, which play important roles in pro-
fibrotic signalling, were absent from this despite being captured. Further extending our 
understanding of immune cells in different pathological states, a study described the immune 
landscape of the human kidney in patients with lupus nephritis, a frequent complication of 
systemic lupus erythematosus
43
. Kidney samples from patients with lupus nephritis and from 
healthy controls were analysed using scRNA-seq. This revealed twenty-one immune clusters 
including numerous subsets of myeloid cells in both pro-inflammatory responses and 
inflammation-resolving responses: inflammatory CD16
+
 macrophages, phagocytic CD16
+
 
macrophages, tissue resident macrophages, M2-like CD16
+
 macrophages, cDCs and pDCs. 
Tissue resident macrophages were the dominant cluster in healthy kidneys.  
Myeloid cells are also increasingly recognised as major players in transplant rejection. Dangi 
and colleagues used scRNA-seq to dissect the contribution of myeloid cell subsets to kidney 
transplant rejection in a mouse model
18
. Thirteen clusters were identified as immune cell 
types, including two macrophage subsets, monocytes, pDC, cDC and a transitioning 
monocyte/macrophage population. As expected, the number of cells in all immune cell 
clusters was the highest in rejecting kidneys followed by tolerised kidneys, and it was 
markedly lower and often negligible in naïve kidneys. A macrophage cluster was the second 
most abundant behind T cells. Interestingly, among the top cluster-defining genes, Axl was 
exclusively expressed only by the graft-infiltrating myeloid cell clusters macrophage cluster 1 
and 2, and the macrophage/monocyte cluster but not by any other cell types. Axl1
+
 
macrophages were found to be significantly higher in rejected versus tolerised kidneys, and 
Axl promoted intragraft differentiation of inflammatory macrophages. In another scRNA-seq 
study, Wu and colleagues analysed a kidney allograft biopsy from a recipient undergoing 
acute rejection
32
. They identified two distinct monocyte populations, likely a 
proinflammatory and classic or intermediate, further supporting a role of myeloid cells in 
kidney rejection in humans. 
Conclusions  
Over the past few years single-cell genomics, with scRNA-seq leading the way, has provided 
researchers with a new experimental toolbox to dissect the roles and interactions of individual 
cell types in health and disease. It is allowing the re-evaluation of our understanding of 
myeloid cell biology in complex organs, including aspects of cellular ontogeny, 
differentiation, homeostasis, and range of activation states. This is especially important in the 
kidney where heterogeneity and plasticity of cells within the myeloid compartment is 
reflected under both homeostatic and disease conditions. Integration of data sets from 
separate experiments using human samples will further be important; humans are genetically 
heterogeneous and have variable environmental exposures, and procurement of enough 
samples can be a challenge. This also highlights the need to continue to determine the 
translatability of our findings. The application of scRNA-seq in both basic and translational 
research is expected to grow exponentially with the continued advancements and 
standardisation of experimental and analytical methods.  
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Monocyte CD11b, Ly6C, CD192 (CCR2), CX3CR1 
 
CD11b, CD14, CD16 
 
Macrophage CD11b, F4/80, CD68, CD64 
 
CD11b, CD68, CD163 
 
         Pro-inflammatory CD86, MHCII 
 
CD86, HLA-DR 
         Anti-inflammatory CD206 (MRC1), IL-4R 
 
CD206 (MRC1), IL-4R 
         Tissue resident  CD192 (CCR2), CD206 (MRC1), CD68, 
CD74, CD81 
 
CD192 (CCR2), CD68, CD74, CD81 
Dendritic cell CD11c, CD11b, MHCII CD11c, CD11b, HLA-DR 
 
         Conventional  CX3CR1, CD103 CD1c (BDCA1), HLA-DR 
 
         Plasmacytoid Ly-49Q, CD317 (Bst2) CD123 (IL-3Rα), CD303 (BDCA2) 
 
Neutrophil CD11b, Ly6G, CD18 
 
CD11b, CD16, CD32, CD66b 
 
Eosinophil CD170 (Siglec-F), CD193 (CCR3) 
 
CD329 (Siglec-8), CD193 (CCR3) 
 
Basophil CD123 (IL-3Rα), FcεRIα CD123 (IL-3Rα), FcεRIα 
 
Mast cell CD117 (c-Kit), FcεRIα 
 
CD32, CD117 (c-Kit), FcεRIα 
 
Table. 1 Examples of markers commonly used to identify populations of myeloid cell 
types in mice and humans. Combinations and levels of expression of markers can vary with 






















Tubula Muris Senis 
https://tabula-muris-senis.ds.czbiohub.org 
Mouse (C57BL6/J) Acute injury  
(LPS-induced endotoxemia) 
scRNA-seq Mouse Kidney Single-cell Expression  
https://connect.rstudio.iu.edu/content/18/  
 
Mouse (CFW) Acute injury  
(IRI) 
































Kidney Interactive Transcriptomics (KIT) 
http://humphreyslab.com/SingleCell/ 
 
Human Healthy (including foetal) scRNA-seq 
 
Kidney Cell Atlas 
https://www.kidneycellatlas.org 





Human Healthy (foetal) scRNA-seq 
 
The Human Nephrogenesis Atlas 
https://sckidney.flatironinstitute.org  
Table. 2 Single-cell atlases. Single-cell expression atlases from studies discussed in this 
review and of interest. R-UUO, reversible unilateral uretic obstruction; FAN, folic acid 






Figure 1. Mapping myeloid cells in kidney injury. For dense tissues like the kidney cell 
dissociation, typically achieved using both physical disaggregation and enzymatic digestion, 
is the most important step; it directly affects the molecular profiles of cells and can introduce 
stress-induced transcriptional artifacts
9,17
. This is particularly limiting when looking at kidney 
disease samples where tissue is subject to inflammatory stress, though it may be overcome by 
excluding low quality cells for example, on the basis of high mitochondrial RNA content
18
. 
Cell isolation and capture is the most unique hurdle to overcome for scRNA-seq. The use of 
FACS allows for the selection of cells based on surface markers and is therefore useful when 
isolating a specific subset of cells for sequencing, including CD45 for immune cells. Adapted 
with permission from [10].  
 
Figure 2. Combining technologies to fully characterise renal immune populations. Using 
sc/sn-RNA-seq together with other historical and novel technologies has enabled the 
identification of new myeloid cell markers. Immune cells may be mapped onto flow 
cytometry plots, for example.  
Figure 1
Figure 2
